Table 4.
In-Hospital Length of stayab (95 % CI) |
P-value | |
---|---|---|
Age | 0.06 (0.05, 0.06) | <.0001 |
Sex | <.0001 | |
Male | Ref | |
Female | −0.55 (−0.66,-0.45) | |
Race/Ethnicity | <.0001 | |
White | Ref | |
Black | 1.33 (1.16, 1.50) | |
Hispanic | 0.18 (−0.02, 0.39) | |
Other | 0.09 (−0.12, 0.30) | |
Residential Income | <.0001 | |
Q4-Highest | Ref | |
Q3 | 0.33 (0.18, 0.47) | |
Q2 | 0.37 (0.22, 0.52) | |
Q1-Lowest | 0.84 (0.68, 1.00) | |
Stage | <.0001 | |
Non-Metastatic | Ref | |
Metastatic | 1.76 (1.65, 1.87) | |
Insurance Type | <.0001 | |
Private | Ref | |
Medicare | 0.66 (0.51, 0.81) | |
Medicaid | 2.91 (2.66, 3.16) | |
Other | 1.72 (1.47, 1.96) | |
Residential Region | <.0001 | |
Large metro | Ref | |
Small metro | −0.36 (−0.48,-0.24) | |
Micropolitan | −0.71 (−0.88,-0.54) | |
Comorbidities | <.0001 | |
0 | Ref | |
1 | 1.52 (1.40, 1.65) | |
≥ 2 | 3.01 (2.82, 3.21) |
aLength of hospital stay was calculated by subtracting the admission date from the discharge date with same-day stays coded as 0
bAdjusted for age, sex, diagnosis year, race, income, stage, insurance, residential region and comorbidities